Get our list of validated markers & panels (IHC/IHF) for immuno-oncology
Since 2015, Explicyte has been providing CRO pathology services for the analysis of preclinical and clinical tumor specimens, treated or not with cancer immunotherapy candidates. Our histopathology platform, assisted by trained pathologists and a dedicated data science team, now totals 150+ validated IHC/IHF markers and 120+ validated panels for immuno-oncology (e.g., T-cell exhaustion, immune contexture, TLS maturity, etc.).
For the past 10 years, Explicyte has been implementing an automated IHC/IHF workflow, from sample preparation to image analysis & data representation, in the context of translational studies:
- Target discovery & validation
- Biomarker discovery & testing
- In vivo studies aimed at deciphering the mechanisms of novel compounds
Learn more about our services in digital pathology
Our digital pathology capacities are now integrated into a comprehensive spatial biology platform dedicated to immuno-oncology:
- Digital histopathology services: automated staining on Ventana systems (2x), high-throughput slide imaging on Akoya systems (2x)
- Digital Spatial Profiling services based on the NanoString GeoMx platform
- Single-Cell Spatial Transcriptomics based on the 10x Xenium analyzer